Pegylated Liposomal Doxorubicin or Epirubicin in Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer.
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Collaborators: CSPC Ouyi Pharmaceutical Co., Ltd.